- €2.60bn
- €2.40bn
- €2.26bn
- 96
- 79
- 54
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,949 | 1,628 | 1,832 | 2,234 | 2,263 |
Cost of Revenue | |||||
Gross Profit | 977 | 783 | 931 | 1,078 | 1,148 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,697 | 1,471 | 1,380 | 1,949 | 1,956 |
Operating Profit | 253 | 157 | 452 | 285 | 307 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 251 | 155 | 448 | 277 | 313 |
Provision for Income Taxes | |||||
Net Income After Taxes | 176 | 93.7 | 314 | 199 | 227 |
Net Income Before Extraordinary Items | |||||
Net Income | 176 | 93.7 | 314 | 199 | 227 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 176 | 93.7 | 314 | 199 | 227 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.15 | 3.07 | 4.25 | 4.91 | 5.76 |
Dividends per Share |